Provided by Tiger Trade Technology Pte. Ltd.

SBP GROUP

5.485
-0.190-3.35%
Volume:82.18M
Turnover:461.49M
Market Cap:102.48B
PE:36.10
High:5.865
Open:5.560
Low:5.475
Close:5.675
52wk High:8.276
52wk Low:4.136
Shares:18.68B
HK Float Shares:18.68B
Volume Ratio:1.89
T/O Rate:0.44%
Dividend:0.12
Dividend Rate:2.24%
EPS(LYR):0.152
ROE:14.07%
ROA:7.51%
PB:2.69
PE(LYR):36.10
PS:2.60

Loading ...

Sino Biopharm (SBP Group) Secures NMPA Green Light and Four-Year Data Protection for Second-Generation Flurbiprofen Patch

Bulletin Express
·
Aug 06

Sino Biopharmaceutical - Second-Generation Flurbiprofen Patch Approved for Marketing

THOMSON REUTERS
·
Aug 06

Sino Biopharmaceutical to Review 1H26 Results and Potential Interim Dividend on 19 August 2026

Bulletin Express
·
Aug 06

Sino Biopharma Schedules Board Meeting to Review Interim Results, Consider Dividend

Reuters
·
Aug 06

Sino Biopharmaceutical Stock Slips 1.2% in Hong Kong

Dow Jones
·
Aug 05

Sino Biopharma Unit's Application for Lymphocytic Leukemia Drug Accepted in China

MT Newswires Live
·
Aug 04

Sino Biopharma Says China CDE Accepts NDA for Tqb3909 BCL-2 Inhibitor in Cll/sll

Reuters
·
Aug 04

Sino Biopharmaceutical - New Drug Application for Tqb3909 Tablet Accepted by China's Cde

THOMSON REUTERS
·
Aug 04

Sino Biopharma Unit Gets Breakthrough Therapy Designation for Cancer Drug in China

MT Newswires Live
·
Aug 03

SBP Group's Third Breakthrough Therapy Designation for TQB2102 Strengthens Its Position in HER2-Targeted Cancer Treatments

Stock News
·
Aug 03

Sino Biopharmaceutical - Tqb2102 Her2 Bispecific ADC Granted Breakthrough Therapy Designation by Cde for Her2-Low Breast Cancer

THOMSON REUTERS
·
Aug 03

Sino Biopharmaceutical Stock Falls 1.7% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 03

SBP GROUP to Present 21 Oncology Studies—Five as Oral Sessions—at 2026 CSCO Annual Meeting

Bulletin Express
·
Jul 30

SBP Group Unveils 21 Studies for Upcoming Oncology Conference, Including 5 Oral Presentations

Stock News
·
Jul 30

Stock Track | SBP GROUP Plummets 5.35% Intraday as Pharmaceutical Sector Faces Broad Selling Pressure

Stock Track
·
Jul 30

Movement Alert|SBP GROUP Falls 3.06% in Regular Trading, Pharmaceutical Sector Under Broad Selling Pressure

Market Focus
·
Jul 30

Sino Biopharmaceutical Stock Rises 2.8% in Hong Kong

Dow Jones
·
Jul 29

Chinese Biopharma Forms Strategic Joint Venture with Tempo Scan to Boost Access to Innovative Drugs in Indonesia

Stock News
·
Jul 27

Sino Biopharmaceutical Forms 51:49 JV With Tempo Scan to Accelerate Innovative Drug Access in Indonesia

Bulletin Express
·
Jul 27

Sino Biopharmaceutical - Enters Joint Venture with Tempo Scan to Establish PT Tempo Cttq Biopharmaceutical Indonesia

THOMSON REUTERS
·
Jul 27